Condensed Consolidated Statements of Operations (Unaudited) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		6 Months Ended		81 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012
Revenues	$ 9		$ 9		$ 9
Cost of sales	171		171		171
Gross margin	(162)		(162)		(162)
Operating costs and expenses
Research and development	769	849	1,947	1,505	14,884
Selling, general and administrative	1,068	467	1,981	1,121	10,977
Total operating costs and expenses	1,837	1,316	3,928	2,626	25,861
Operating loss	(1,999)	(1,316)	(4,090)	(2,626)	(26,023)
Other income and expense
Other income					1,147
Interest income, net					79
Amortization of deferred financing cost	(3)	(6)	(5)	(31)	(1,975)
Interest exp			(43)		(155)
Total other income and expense	(3)	(6)	(48)	(31)	(904)
Loss before income tax	(2,002)	(1,322)	(4,138)	(2,657)	(26,927)
Provision for income tax
Net loss	(2,002)	(1,322)	(4,138)	(2,657)	(26,927)
Loss attributable to common stockholders and loss per common share:
Net loss	(2,002)	(1,322)	(4,138)	(2,657)	(26,927)
Net loss attributable to common stockholders	(2,002)	(1,322)	(4,138)	(2,657)	(32,293)
Weighted average shares outstanding, basic and diluted	48,798	28,004	43,314	28,004
Net loss per basic and diluted share	$ (0.04)	$ (0.05)	$ (0.10)	$ (0.09)
Series A Preferred Conversion
Loss attributable to common stockholders and loss per common share:
Deemed dividend					(4,301)
Series A Preferred Stock
Loss attributable to common stockholders and loss per common share:
Deemed dividend					(700)
Dividends - Series A Preferred Stock					$ (366)